Sign Up
Stories
Biotech Advancements in Hearing Loss Treatments
Share
Biotech Startups and Gene Therapy for He...
AudioCure Pharma's Hearing Technology In...
BioSenic's Progress and Patent
Biotech and Copper Mining Updates
Overview
API
Sensorion, a biotechnology company specializing in hearing loss disorders, is attending the 42nd Annual J.P. Morgan Healthcare Meeting in San Francisco and participating in the Jefferies London Healthcare Conference and McDermott Will Emery’s Life Sciences Symposium. Two companies, Akouos and Decibel Therapeutics, have launched clinical trials to restore hearing in children with OTOF gene mutations. Regeneron Pharmaceuticals has announced its acquisition of Decibel Therapeutics, strengthening its gene therapy programs for hearing loss.
Ask a question
How might the advancements in biotechnology and gene therapy impact the treatment and prevention of hearing loss disorders in the future?
How might the clinical trials for restoring hearing in children with OTOF gene mutations influence the development of other treatments for hearing loss disorders?
What are the potential implications of the acquisition of Decibel Therapeutics by Regeneron Pharmaceuticals for the gene therapy programs in hearing loss?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jul 2023
Sep 2023
Nov 2023
Coverage